Matthew Dias

Title: Innovations of Matthew Dias in DNA Topoisomerase Inhibitor Discovery.

Introduction

Matthew Dias is an accomplished inventor based in Miami, FL (US). He has made significant contributions to the field of molecular biology, particularly in the discovery of DNA topoisomerase inhibitors. His innovative approach has led to the development of a novel assay that enhances the screening process for potential inhibitors.

Latest Patents

Matthew Dias holds a patent for a "High throughput screening assay to identify DNA topoisomerase inhibitors." This invention provides a fluorescence-based, T5 exonuclease-amplified DNA cleavage assay for gyrase poisoning inhibitor discovery. The assay allows multiple gyrase molecules to bind simultaneously to a plasmid DNA molecule, forming multiple gyrase-DNA cleavage complexes. These complexes are stabilized by gyrase poisoning inhibitors and can be trapped using detergents like sarkosyl. The subsequent digestion of gyrase by proteinase K produces small DNA fragments, which can be further digested by T5 exonuclease. This fluorescence-based DNA cleavage HTS assay is also suitable for screening large compound libraries to identify inhibitors against DNA topoisomerases, including human DNA topoisomerase IIα.

Career Highlights

Matthew Dias is affiliated with Florida International University, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential applications in drug discovery and therapeutic development.

Collaborations

Matthew collaborates with Fenfei Leng, contributing to the advancement of their shared research interests.

Conclusion

Matthew Dias is a notable inventor whose work in developing a high throughput screening assay has the potential to significantly impact the field of molecular biology and drug discovery. His innovative contributions continue to pave the way for future advancements in identifying DNA topoisomerase inhibitors.